This is a huge milestone. Yield was our priority, and we have been working hard to reach these performances on time. Now, while keeping on increasing this yield, we will intensify our efforts aiming at accelerating the process flux, using first and second generation sugars.

—Romain Chayot, head of the metabolic engineering department (Earlier post.)

Marc Delcourt, CEO of Global Bioenergies, said that the company should approach commercial performances at demo plant scale by mid-2017, allowing it to launch the construction of the first bio-isobutene commercial plant (IBN-One).

Isobutene is a key chemical building block that can be converted into transportation fuels, polymers and various commodity chemicals.